GE Healthcare climbs after better-than-expected quarterly results
BUZZ-GE Healthcare climbs after better-than-expected quarterly results ** Shares of medical device maker GE Healthcare GEHC.O rise 10.8% to $71 premarket
** Co reports Q2 adj. EPS of $1.13, above analysts' avg. estimate of $1.04/share - LSEG data
** Co posts Q2 sales of $5.30 bln, above expectations of $5.26 bln
** On patient care solutions, CEO Peter Arduini says co is focused on returning the business to growth and profitability, while reviewing strategic options to maximize its long-term value
** "Global geopolitical instability, including the conflict in the Middle East, adversely impacted our costs, supply chains, and logistics during the second quarter of 2026" - GEHC regulatory filing
** As of last close, stock down 21.8% YTD
(Reporting by Kamal Choudhury in Bengaluru)
Recent news on GE HealthCare Technologies
See all newsBrief: GE Healthcare Expands General Imaging Ultrasound Portfolio With Logiq Focus
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
GE HealthCare slip after $945 million deal for Sofie Biosciences